Related Experiment Videos
Insights
Treating insulin-induced lipoatrophy in children involves injecting insulin directly into the affected area. Both monocomponent and less purified insulins are effective when administered this way.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
Background:
- Insulin-induced lipoatrophy is a common complication of insulin therapy in children.
- This condition affects subcutaneous fat distribution at injection sites.
Purpose of the Study:
- To evaluate the efficacy of treating insulin-induced lipoatrophy by injecting insulin into the lipoatrophic area in children.
- To compare the effectiveness of monocomponent versus less purified insulins in this treatment approach.
Main Methods:
- Twenty children with insulin-induced lipoatrophy were included in the study.
- Insulin was injected directly into the lipoatrophic areas for all participants.
- Ten children received monocomponent insulins, while the other ten continued with their previous less purified insulins.
Main Results:
- Successful treatment of insulin-induced lipoatrophy was observed in all twenty children.
- Both monocomponent and less purified insulins demonstrated efficacy in resolving lipoatrophy when injected into the affected sites.
Conclusions:
- Direct injection of insulin into lipoatrophic areas is an effective treatment strategy for children.
- The type of insulin, whether monocomponent or less purified, does not impede successful treatment of lipoatrophy when administered correctly.
Abstract:
Twenty children with insulin-induced lipoatrophy were successfully treated by injecting the insulin into the lipoatrophic area. In 10 children insulin therapy was replaced by monocomponent insulins, while the other 10 children were treated with the insulins they previously used. It is concluded that both monocomponent and less purified insulins are suitable for treating the complication of insulin therapy when the insulin is injected into the lipoatrophic area.